Alumis ALMS
NASDAQ ALMS
$11.10 -0.26 (-2.29%)
As of: Sep 4, 2026 · 3:59 PM EDT

Alumis (ALMS) Cash & Current Investments (2023 - 2026)

Alumis (ALMS) posted quarterly Cash & Current Investments of $308.5 million for Q4 2025, up 7.02% year-over-year from $288.3 million in Q4 2024, and down 18.33% quarter-over-quarter from $377.7 million in Q3 2025.

Analysis

Alumis (ALMS) Cash & Current Investments (2023 - 2026) Analysis & Trends

Alumis (ALMS) has reported Cash & Current Investments for 3 consecutive years, with $308.5 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Cash & Current Investments rose 7.02% year-over-year to $308.5 million; the TTM figure through Dec 2025 stood at $308.5 million (up 7.02% YoY), while the FY2025 annual figure was $308.5 million, up 7.02% from the prior year.
  • Cash & Current Investments declined to $308.5 million in Q4 2025 per ALMS's latest filing, from $377.7 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $377.7 million in Q3 2025 and bottomed at $49.0 million in Q4 2023.
  • Historically, Cash & Current Investments has averaged $195.2 million across 3 years, with a median of $155.2 million in 2024.
  • Annual changes were most pronounced in 2024 — Cash & Current Investments soared 566.97% — and 2025, when it fell 2.0%.
  • Alumis' Cash & Current Investments stood at $49.0 million in 2023, then jumped by 488.87% to $288.3 million in 2024, then increased by 7.02% to $308.5 million in 2025.
  • Business Quant data shows ALMS's Cash & Current Investments at $308.5 million in Q4 2025, $377.7 million in Q3 2025, and $152.1 million in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 7.85 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 7.99 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 5.18 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.14 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 5.10 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 3.31 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 836.99 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1.16 Bn
10 Alumis 1.42 Bn 919.00 Mn - 502.29 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 502.29 Mn
Dec 31, 2025 308.50 Mn
Sep 30, 2025 377.72 Mn
Jun 30, 2025 152.12 Mn
Mar 31, 2025 208.75 Mn
Dec 31, 2024 288.26 Mn
Sep 30, 2024 361.87 Mn
Jun 30, 2024 155.22 Mn
Mar 31, 2024 112.07 Mn
Dec 31, 2023 48.95 Mn
Sep 30, 2023 54.26 Mn
Jun 30, 2023 79.77 Mn